Integrity in Action: Celebrating Corporate Ethics and Compliance Week
In recognition of Corporate Ethics and Compliance Week, we’re celebrating this commitment through a series of discussions, activities, and events designed to engage our employees around the world...
Leading with Integrity Starts by Creating Psychological Safety
By: Coleen Glessner, Executive Vice President, Quality, Ethics, and Compliance As leaders, it’s important that colleagues feel that they can share their voice, ask any questions, and raise...
How veterans are making an impact at Emergent and beyond
The values and experiences of veterans play a vital role in helping us achieve our mission to protect and enhance life. A proud supporter of the military and veteran community, Emergent is a place...
Partnering with small and diverse companies
We’ve made a commitment to actively pursue opportunities to work with small businesses that are minority-owned, women-owned, veteran-owned, disability-owned, LGBTQ-owned, and small businesses that...
Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of exclusive worldwide rights to...
Remembering 9/11: Emergent employees reflect on the events of September 11th
This Sunday, as another year passes since the September 11, 2001 terrorist attacks, we collectively reflect on its enduring legacy, and continue to honor the memory of those who lost their lives that...
Kelly Warfield: We’re Preparing for the Worst Possible Disasters, So You Can Be Prepared
Soon after the September 11th attacks, letters containing powdered anthrax were sent to media agencies and United States Senate offices, exposing hundreds, potentially thousands, of people to deadly...
Atul Saran: Now is The Time for Bold Action on Public Health Preparedness
With the last 2.5 years so fresh in our minds, it seems hard to believe that we will move past the deaths, the shutdowns, the mask mandates, the spikes in cases and variants and so much more the...
Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics...
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
Expands and further diversifies Emergent’s medical countermeasures portfolio with the addition of a small molecule therapeutic addressing a high priority public health threat Transaction to be...